Executive Team


Kevan Shokat, Ph.D

Co-Founder, Chairman of the Scientific Advisory Committee

  • National Academy of Sciences
  • Howard Hughes Investigator at the University of California San Francisco
  • Professor of Chemistry at the University of California, Berkeley
  • Companies: IntelliKine, Wellspring, CGI Pharmaceuticals, Kura Oncology, eFFECTOR


Nicholas Hertz, Ph.D

Co-Founder, Chief Science Officer

  • Helen Hay Whitney Postdoctoral Fellow at Stanford University (Dr. Marc Tessier-Lavigne)
  • BSc in Biochemistry from UCLA (Phi Beta Kappa, Magna Cum Laude)
  • Ph.D in Chemistry and Chemical Biology UCSF


Daniel de Roulet Jr

Co-Founder, Chief Executive Officer

  • Previously Partner of Bishop & Carroll Capital Partners, LLC
  • Previously US Equity Analyst and Portfolio Manager for LaBranche & Co, LLC
  • B.A. in Economics from Columbia University in 2004

Scientific Advisory Board/Advisor


M. Flint Beal, M.D.

Scientific Advisory Board

  • Former Chairman of Neurology, New York Hospital
  • Professor of Neuroscience at the Weill Medical College of Cornell University
  • Distinguished HD/PD researcher

X. William Yang, M.D., Ph.D.

Scientific Advisory Board

  • Professor at UCLA Center for Neurobehavioral Genetics
  • Distinguished HD/PD researcher
  • Expert in in-vivo models of HD and PD

Ray Truant, Ph.D.

Scientific Advisory Board

  • Professor of Biochemistry at McMaster University in Canada
  • Chairman of the Scientific Advisor Board of the Huntington’s Society of Canada

Investors and Partners